AstraZeneca Completes Divestment Of Movantik Drug To RedHill Read More
AstraZeneca's Farxiga Trial Ends Early Due To "Overwhelming Efficacy" Read More
AstraZeneca's Hyperkalaemia Drug Lokelma Gets Approval In Japan Read More
UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend Read More
Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca Read More
UK Dividends Calendar - Next 7 Days Read More
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares Read More
Japan Gives AstraZeneca's Lynparza Orphan Status In Pancreatic Cancer Read More
UK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa Read More
AstraZeneca's Caspian Trial Confirms Survival Benefit Of Imfinzi Read More
AstraZeneca's Lynparza, Cediranib Trial Fails To Meet Primary Endpoint Read More
AstraZeneca's Phase III Danube Trial Fails To Meet Primary Endpoint Read More
LONDON MARKET PRE-OPEN: Cineworld Reports "Good" Demand Despite Virus Read More
AbbVie Gets European Approval For Brazikumab Sale To AstraZeneca Read More
AstraZeneca Divests Five Hypertension Drugs For Up To USD390 Million Read More
DIRECTOR DEALINGS SUMMARY: Ocado Chair Rose Sells GBP1.7 Million Worth Read More
TOP NEWS: AstraZeneca Divests Movantik Rights In USD68 Million Deal Read More
DIRECTOR DEALINGS: AstraZeneca Non-Executive Director Buys Shares Read More
UK BROKER RATINGS SUMMARY: JPMorgan Upgrades Severn Trent To Neutral Read More
